patent
Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
December 22, 2022
The invention provides anti-SARS-CoV-2 antibodies and use thereof in prophylaxis, treatment and/or attenuation of a SARS-CoV-2 virus infection.
Type
patent
EPO Family ID
82308225
Author(s)
Note
Alternative title(s) : (fr) Anticorps anti-sars-cov-2 et leur utilisation dans le traitement d'une infection par le sars-cov-2
TTO classification
TTO:6.2181
EPFL units
| DOI | Country code | Kind code | Date issued |
WO2022263638 | WO | A1 | 2022-12-22 |
Available on Infoscience
February 6, 2023
Use this identifier to reference this record